INTRODUCTION
Despite the immunologic abnormalities described in chronic lymphocytic leukemia (CLL)1 only a few differences have been documented between the lymphocytes found in normal subjects and patients with CLL. These include the decreased response to phytohemagglutinin stimulation (1) , an altered hybridization pattern of the RNA (2) , and the high percentage of cells bearing surface immunoglobulins in CLL (3) . A membrane abnormality in these cells was suggested in the recent finding that CLL lymphocytes have fewer binding sites for mitogens than normal lymphocytes (4) .
In an extension of studies on human lymphocyte membranes in which 'the activity of 5'-nucleotidase was used as a plasma membrane marker (5), a striking difference was observed between normal lymphocytes and the cells of most patients with CLL: While 5'-nucleotidase was present in plasma membranes purified from lymphocytes found in the blood of normal subjects, the activity was markedly decreased or absent in similar fractions prepared from the patients' lymphocytes. Table I . Whereas a relatively narrow range of values was obtained with these lymphocyte membranes, S'-nucleotidase activity was absent or barely detectable in membrane preparations from 7 out of the 10 patients with CLL studied. Increasing the amount of protein in the assay to four times the level used with lymphocyte membranes from normals and lengthening the incubation time of the reaction mixture from the standard 20 min to 2 h was needed to reveal any activity in these preparations. The assays were repeated on fresh lymphocyte membranes prepared from three patients on several different occasions at intervals of 1-8 wk; the patients deficient in lymphocyte membrane 5' nucleotidase on one occasion always lacked activity when tested on fresh lymphocytes membranes prepared from subsequent blood samples. There was no relationship between the white blood cell count and 5'-nucleotidase level in the CLL patients studied.
METHODS
In order to determine whether the failure to detect enzyme activity could be attributed to the presence of an inhibitor in the CLL membrane, a "mixing" experiment was performed. When membranes from a normal and a CLL lymphocyte preparation lacking 5'-nucleotidase .pI J. were incubated separately and in a series of mixtures of varying proportions, the 5'-nucleotidase specific activity corresponded with the values predicted from the ratio of the two membrane preparations in the mixture. This finding rules out the presence of an inhibitor in the CLL or of an activator in the normal membrane.
Conceivably, the lack of 5'-nucleotidase on the membrane of CLL lymphocytes could reflect a difference in subcellular fractionation behavior from normal lymphocytes leading to contamination of membrane preparations in the CLL membranes, with nonmembrane protein, thereby resulting in lower specific activities in these cells. The following three experimental observations provided strong evidence against this possibility: (a) There was no difference in the morphology or the purity of the membranes prepared from lymphocytes of normal subjects and those from patients with CLL when examined with the electron microscope ( Fig. la and b) .
(b) The specific activity of NADH diaphorase, another plasma membrane marker (8), was not diminished in CLL lymphocytes (9) . (c) When the 5' nucleotidase activity was determined in crude homogenates of lymphocytes from four patients whose membrane preparations were deficient in enzyme, the activity was also lacking in the crude preparation from which the membranes were derived (Table II) . The enzyme was readily detected in the crude homogenate of lymphocytes from patient Smo. whose membrane activity is shown in Table I . A "mixing" experiment performed with crude homogenates from normal and CLL lymphocytes did not detect an inhibitor or activator of 5'-nucleotidase activity.
Since it has been reported that an increased proportion of the lymphocytes in the blood of patients with CLL are cells of bone marrow origin (B lymphocytes), the possibility was considered that the lack of 5'-nucleotidase reflected a shift in the type of lymphocyte rather than the neoplastic process. Although studies in patient Sen. who had a normal and DeB. with decreased activity 5'-Nucleotidase in Lymphocytes failed to establish a correlation between the enzyme level and percentage of B cells, a definitive answer to this question awaits the development of methods to separate B and T cells in man (3, 10) .
DISCUSSION
The data presented above suggest that lymphocytes from patients with CLL fall into at least two groups based on the presence of the membrane marker 5'-nucleotidase. This view is consistent with the kinetic and immunologic evidence of heterogeneity. It is also supported by the finding of a decreased level of the lysosomal enzymes P-glucuronidase and acid phosphatase in the cells of some patients with CLL (11) . Further studies are required to determine the possible effect of cell age, bone marrow vs. thymic origin, or the clinical course of the disease on this enzyme. Studies on 5'-nucleotidase in lymphocytes from patients with other diseases are also warranted to determine the effect of other clinical conditions on its activity. Purification of the enzyme and preparation of an antibody will be needed to determine if the enzyme protein is actually lacking or whether instead, the decreased activity reflects instability or functional impairment.
Since the in vivo function of 5'-nucleotidase in eukaryotic cells (or even of the highly purified Escherichia coli enzyme [12] ) is not certain, the significance of the decrease in activity reported above must remain conjectural. Based on the in vitro specificity, at least two roles for membrane 5'-nucleotidase can be envisaged. The enzyme catalyzes the degradation of 5'-mononucleotides to nucleosides and therefore may be of importance in determining the level of precursors available for the polymerization reactions leading to nucleic acid synthesis. In addition, 5'-nucleotidase in E. coli (12) has been shown to hydrolyze uridine diphosphate glucose (UDPG) and therefore may play a role in the catabolism of this compound which is a major cofactor in the biosynthesis of the sugar moiety of membrane glycoproteins. An impaired function of 5'-nucleotidase, either by increasing the pools of 5'-nucleotides for macromolecular synthesis or by influencing the level of UDPG might be of advantage to a neoplastic cell. This concept is supported by the recent finding of a marked decrease in 5'-nucleotidase activity during liver regeneration (13) .
